Weissleder

Home

About

Ralph Weissleder's Lab

Weissleder_research

The Lab has a unique operation. We have always focused on selecting ideas that would have the greatest positive impact for humanity (for some current projects see here). Our primary focus is to:

  • Obtain a deeper understanding of human biology in health and disease
  • Translate new biological understanding into clinically useful diagnostics
  • Identify new therapeutic approaches and drug targets
The lab uses a variety of tools and platforms (bioimaging, chemical biology, bioengineering) for data acquisition. In general, we aim at obtaining:
  • Quantitative in vivo measurements
  • Systems-wide global measurements
  • Dynamic, serial measurements
  • An fine-grained understanding of in vivo function
We strongly encourage an unusual interdisciplinary approach, fostering collaboration between scientists and clinicians from diverse backgrounds. This convergence approach has led to many exciting discoveries and innovations at the Weissleder Lab.

Recent Publications (more...)

Dubach JM, Kim E, Yang K, Cuccarese M, Giedt RJ, Meimetis LG, Vinegoni C, Weissleder R
Quantitating drug-target engagement in single cells in vitro and in vivo.
Nat Chem Biol. 2016;:ePub - PMID: 27918558
Weissleder R, Schwaiger MC, Gambhir SS, Hricak H
Imaging approaches to optimize molecular therapies
Sci Transl Med. 2016;8(355):355ps16 - PMID: 27605550
Hong S, Pirovich D, Kilcoyne A, Huang CH, Lee H, Weissleder R
Supramolecular Metallo-Bioadhesive for Minimally Invasive Use
Adv Mater. 2016;28(39):8675-8680 - PMID: 27515068 - PMCID: PMC5144581
Gee MS, Ghazani AA, Haq R, Wargo JA, Sebas M, Sullivan RJ, Lee H, Weissleder R
Point of care assessment of melanoma tumor signaling and metastatic burden from μNMR analysis of tumor fine needle aspirates and peripheral blood.
Nanomedicine. 2016;:ePub - PMID: 27993725

Recent News (more...)

2016-12-14: Sean Arlauckas, PhD of the Weissleder Lab received the honor of “Top Poster” at the 2nd Annual Symposium of the Harvard Program in Therapeutic Sciences. Congratulations, Sean!
2016-12-13: Ralph Weissleder, MD, PhD has been elected as a member of the National Academy of Inventors. The NAI Fellows Selection Committee has chosen Ralph for induction as he “has demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.” Congratulations on this great achievement and recognition as a truly prolific academic inventor!
2016-10-07: Divya Pathania, PhD was selected to receive Translational Research Award for Lymphoma-D3 project at MGH Clinical Research Day. Congratulations, Divya!
2016-08-18: Two CSB fellows - Kisoo Park, PhD and Christina Pfirschke, PhD - have been selected to receive a MGH ECOR Tosteson Postdoctoral Fellowship Award. The Tosteson Awards are given to the top-ranked applicants for the Fund for Medical Discovery Postdoctoral Awards. Congratulations, Kisoo and Christina!
2016-06-01: Seonki Hong (Poster of Prestige), Chen-Han Huang (Poster of Merit), and Ashley Fenn (Poster of Distinction) received awards at 2016 MGH ORCD Research Fellows Poster Celebration. Congratulations!